Although TNF-α was identified as promising cancer therapeutic and several agonists were developed for that purpose, TNF-α antagonists have a greater value in treating inflammatory and autoimmune diseases (rheumatoid arthritis) [96,217]. This evidence concerns the gene TNF and cancer.